Somatostatin analogue

This page covers all Somatostatin analogue drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Somatostatin receptors (SSTR2, SSTR5), Somatostatin receptor.

Targets

Somatostatin receptors (SSTR2, SSTR5) · Somatostatin receptor

Marketed (1)

• combination with somatostatin analogue octreotide · Ludwig-Maximilians - University of Munich · Oncology
  Octreotide is a somatostatin analogue that binds to somatostatin receptors to inhibit the secretion of various hormones and growth factors.

Phase 3 pipeline (1)

• Placebo lanreotide · University Hospital, Limoges · Endocrinology
  Lanreotide is a somatostatin analogue that inhibits the release of growth hormone and other hormones.